| Drug Name |
Ropivacaine hydrochloride monohydrate |
| Drug ID |
BADD_D01969 |
| Description |
Ropivacaine is an aminoamide local anaesthetic drug commonly marketed by AstraZeneca under the trade name Naropin. It is present as a racemic mixture of the enantiomers containing equal proportions of the “S” and “R” forms. The marketed form contains the single S-enantiomer as the active ingredient. |
| Indications and Usage |
Used in obstetric anesthesia and regional anesthesia for surgery. |
| Marketing Status |
approved |
| ATC Code |
N01BB09 |
| DrugBank ID |
DB00296
|
| KEGG ID |
D08490; D04048
|
| MeSH ID |
D000077212
|
| PubChem ID |
6918111
|
| TTD Drug ID |
D09RHQ
|
| NDC Product Code |
72375-0004; 66583-0610 |
| UNII |
V910P86109
|
| Synonyms |
Ropivacaine | 1-Propyl-2',6'-pipecoloxylidide | 1 Propyl 2',6' pipecoloxylidide | Naropin | Ropivacaine Monohydrochloride | Ropivacaine Hydrochloride | AL 381 | AL-381 | AL381 | Naropeine | LEA 103 | LEA-103 | LEA103 | Ropivacaine Monohydrochloride, (S)-isomer |
